Mitsutoshi Yamamoto

4.2k total citations
69 papers, 2.1k citations indexed

About

Mitsutoshi Yamamoto is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Mitsutoshi Yamamoto has authored 69 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 22 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in Mitsutoshi Yamamoto's work include Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (16 papers) and Neuroscience and Neuropharmacology Research (10 papers). Mitsutoshi Yamamoto is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (16 papers) and Neuroscience and Neuropharmacology Research (10 papers). Mitsutoshi Yamamoto collaborates with scholars based in Japan, United States and Austria. Mitsutoshi Yamamoto's co-authors include Yoshikuni Mizuno, Sadako Kuno, Nobutaka Hattori, Tatsushi Toda, Miho Murata, Ikuko Kondo, Kazuko Hasegawa, Tomoyoshi Kondo, Takeo Nakayama and Ikuko Mizuta and has published in prestigious journals such as PLoS ONE, Neurology and The Lancet Neurology.

In The Last Decade

Mitsutoshi Yamamoto

68 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsutoshi Yamamoto Japan 28 1.4k 705 445 327 267 69 2.1k
Silvia Cerri Italy 26 1.1k 0.7× 584 0.8× 714 1.6× 473 1.4× 336 1.3× 61 2.3k
Dilan Athauda United Kingdom 19 1.3k 0.9× 722 1.0× 636 1.4× 488 1.5× 323 1.2× 31 2.4k
Jinsha Huang China 22 810 0.6× 428 0.6× 631 1.4× 343 1.0× 370 1.4× 47 2.0k
Asako Yoritaka Japan 20 1.2k 0.8× 584 0.8× 690 1.6× 436 1.3× 311 1.2× 48 2.2k
Annick Prigent France 13 1.3k 0.9× 905 1.3× 601 1.4× 464 1.4× 1.0k 3.8× 17 2.6k
Wenjie Xie China 23 822 0.6× 723 1.0× 687 1.5× 329 1.0× 399 1.5× 55 2.1k
Anmu Xie China 25 743 0.5× 397 0.6× 723 1.6× 407 1.2× 350 1.3× 99 2.1k
Ayşe Ulusoy Germany 22 1.4k 1.0× 808 1.1× 625 1.4× 415 1.3× 351 1.3× 36 2.0k
Yvette Bordelon United States 26 1.6k 1.1× 834 1.2× 499 1.1× 404 1.2× 368 1.4× 70 2.5k
Mark Frasier United States 15 1.0k 0.7× 449 0.6× 379 0.9× 448 1.4× 264 1.0× 28 1.5k

Countries citing papers authored by Mitsutoshi Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Mitsutoshi Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsutoshi Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsutoshi Yamamoto more than expected).

Fields of papers citing papers by Mitsutoshi Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsutoshi Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsutoshi Yamamoto. The network helps show where Mitsutoshi Yamamoto may publish in the future.

Co-authorship network of co-authors of Mitsutoshi Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsutoshi Yamamoto. A scholar is included among the top collaborators of Mitsutoshi Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsutoshi Yamamoto. Mitsutoshi Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toyama, Mayumi, Yasuyuki Okuma, Mitsutoshi Yamamoto, et al.. (2019). Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study. Journal of the Neurological Sciences. 412. 116641–116641. 5 indexed citations
2.
Yamamoto, Mitsutoshi, et al.. (2018). The latest waste incineration facility with energy supply function. 2018.28(0). 207–207. 1 indexed citations
3.
Ikeda, Ryosuke, et al.. (2017). Effect of the Surface Texture Treatment (Wavy Plate) on the Liquid Film Flow on a Plate of Packings. JAPANESE JOURNAL OF MULTIPHASE FLOW. 30(5). 475–482.
4.
Ishizaki, Tatsuro, Hisashi Urushihara, Toshihiko Satoh, et al.. (2014). Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010. PLoS ONE. 9(6). e99021–e99021. 30 indexed citations
5.
Yamamoto, Mitsutoshi. (2013). Practical guideline of Parkinson’s disease in Japan: evaluation and mission of future. Rinsho Shinkeigaku. 53(11). 1352–1353. 1 indexed citations
6.
Sawada, Hideyuki, Tomoko Oeda, Sadako Kuno, et al.. (2010). Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial. PLoS ONE. 5(12). e15298–e15298. 108 indexed citations
7.
Mizuta, Ikuko, Tatsuhiko Tsunoda, Wataru Satake, et al.. (2008). Calbindin 1, fibroblast growth factor 20, and α-synuclein in sporadic Parkinson’s disease. Human Genetics. 124(1). 89–94. 47 indexed citations
8.
Yamamoto, Mitsutoshi & Anthony H.V. Schapira. (2008). Dopamine agonists in Parkinson’s disease. Expert Review of Neurotherapeutics. 8(4). 671–677. 28 indexed citations
9.
Mizuno, Yoshikuni, Takashi Abe, Kazuko Hasegawa, et al.. (2007). Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Movement Disorders. 22(13). 1860–1865. 37 indexed citations
10.
Yamamoto, Mitsutoshi, et al.. (2007). Dopamine agonists and valvular heart disease in patients with Parkinson's disease: evidence and mystery. Journal of Neurology. 254(S5). 74–78. 4 indexed citations
11.
Kobayashi, Hideaki, Hiroshi Ujike, Junko Hasegawa, et al.. (2006). Correlation of tau gene polymorphism with age at onset of Parkinson's disease. Neuroscience Letters. 405(3). 202–206. 8 indexed citations
12.
Kobayashi, Hideaki, Hiroshi Ujike, Junko Hasegawa, et al.. (2006). Identification of a risk haplotype of the α‐synuclein gene in Japanese with sporadic Parkinson's disease. Movement Disorders. 21(12). 2157–2164. 2 indexed citations
13.
Yamamoto, Mitsutoshi. (2001). Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background. Journal of Neurology. 248(S3). III5–III11. 55 indexed citations
14.
Ujike, Hiroshi, Mitsutoshi Yamamoto, Akihiro Kanzaki, et al.. (2001). Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease. Movement Disorders. 16(1). 111–113. 14 indexed citations
15.
Oana, Yasunori, Masato Matsuura, Shinichi Yoshioka, et al.. (1998). A Multi-Institutional Study of a Japanese Version of the Side Effects and Life Satisfaction (SEALS). Journal of the Japan Epilepsy Society. 16(1). 1–8. 4 indexed citations
16.
Yamamoto, Mitsutoshi, Ikuko Kondo, Norio Ogawa, et al.. (1997). Genetic association between susceptibility to Parkinson's disease and α1-antichymotrypsin polymorphism. Brain Research. 759(1). 153–155. 28 indexed citations
17.
Yamamoto, Mitsutoshi, et al.. (1996). Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. Journal of Neural Transmission. 103(7). 843–849. 33 indexed citations
18.
Ogawa, Norio, et al.. (1994). Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine. Neuroscience Letters. 171(1-2). 55–58. 51 indexed citations
19.
Ogawa, Norio, et al.. (1984). Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues. Peptides. 5(4). 743–746. 25 indexed citations
20.
Yamamoto, Mitsutoshi, Saburo Otsuki, Hiroo Kuroda, & Norio Ogawa. (1983). Isoniazid effects on choreiform movement and on GABA, HVA and 5-HIAA in CSF. Acta Neurologica Scandinavica. 67(2). 124–127. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Cerri Breakdown of academic impact, for papers by Dilan Athauda Breakdown of academic impact, for papers by Jinsha Huang Breakdown of academic impact, for papers by Asako Yoritaka Breakdown of academic impact, for papers by Annick Prigent Breakdown of academic impact, for papers by Wenjie Xie Breakdown of academic impact, for papers by Anmu Xie Breakdown of academic impact, for papers by Ayşe Ulusoy Breakdown of academic impact, for papers by Yvette Bordelon Breakdown of academic impact, for papers by Mark Frasier
Rankless by CCL
2026